{
  "id": "mhgap#referral_95ca0ddf",
  "content": "– compared with no treatment, show little to no – compared with TAU, shows little to no effect for:\ncontinuous abstinence at the end of treatment\ndifference for: point abstinence at the end of\nand on longest period of abstinence (very\ntreatment (high certainty), and point abstinence\nlow certainty).\nand continuous abstinence at longest follow-up\n(low certainty); y In adults with stimulant dependence, contingency\nmanagement:\n– compared with TAU, show effect for: decreasing\ndropouts from treatment (moderate certainty), – compared with no treatment, shows effect for:\nand increasing point abstinence at the end reducing dropouts (low certainty), increasing\nof treatment and at longest follow-up (very continuous abstinence at the end of treatment\nlow certainty); and point abstinence at longest follow-up,\nincreasing longest period of abstinence,\n– compared with TAU, show little to no difference\nand decreasing frequency of drug intake\nfor: continuous abstinence at end of treatment\n(moderate certainty);\n(low certainty), increasing continuous abstinence\nat longest follow-up, and longest period of – compared with no treatment, shows little to\nabstinence (very low certainty). no difference for: point abstinence at the end\nof treatment (low certainty), and point and\ny In adults with stimulant dependence, CBT:",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Referral – compared with no treatment, show little to no – compared with TAU, shows little to no effect for:\ncontinuous abstinence at the end of treatment\ndifference for: point abstinence at the end of\nand on longest period of abstinence (very\ntreatment (high certainty), and point abstinence\nlow certainty).\nand continuous abstinence at longest follow-up\n(low certainty); y In adults with stimulant dependence, contingency\nmanagement:\n– compared with TAU, show effect for: decreasing\ndropouts from treatment (moderate certainty), – compared with no treatment, shows effect for:\nand increasing point abstinence at the end reducing dropouts (low certainty), increasing\nof treatment and at longest follow-up (very continuous abstinence at the end of treatment\nlow certainty); and point abstinence at longest follow-up,\nincreasing longest period of abstinence,\n– compared with TAU, show little to no difference\nand decreasing frequency of drug intake\nfor: continuous abstinence at end of treatment\n(moderate certainty);\n(low certainty), increasing continuous abstinence\nat longest follow-up, and longest period of – compared with no treatment, shows little to\nabstinence (very low certainty). no difference for: point abstinence at the end\nof treatment (low certainty), and point and\ny In adults with stimulant dependence, CBT: – compared with no treatment, show little to no – compared with tau, shows little to no effect for:\ncontinuous abstinence at the end of treatment\ndifference for: point abstinence at the end of\nand on longest period of ab..."
}